RedHill Biopharma (RDHL) Jumps: Stock Up 8.8% - Tale of the Tape

Zacks Equity Research

Updated Thu, Jun 25, 2015, 9:46 AM

RedHill Biopharma Ltd. (RDHL) was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume with far more shares changing hands than in a normal session. With this, the recent uptrend for the company continues as the stock is now up 21.7% in the last one month.

The company has seen no estimate revisions in the past 30 days and the Zacks Consensus Estimate has also remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

RedHill Biopharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked biotechnology stock is Valeant Pharmaceuticals International, Inc. (VRX), sporting a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

REDHILL BIO-ADR (RDHL): Free Stock Analysis Report

VALEANT PHARMA (VRX): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Dow Jones Futures Fall As Israel Strikes Iran; Stock Market About To Break Power Trend
Futures fell on reports of Iran explosions: The market power trend is about to end. Netflix gave weak guidance.
Investor's Business Daily•4m ago
Don't buy the dip in stocks just yet as a wave of selling is about to bring the market to a bottom, according to one of the biggest bulls on Wall Street
The S&P 500 could bottom out in the next month, according to Fundstrat's head of research Tom Lee.
Business Insider•4h ago
Stocks Slump, Havens Surge on Mideast: Markets Wrap
(Bloomberg) -- Global markets were rocked by fresh conflict in the Middle East that sent stocks lower while oil and haven assets including Treasures and the dollar rallied.Most Read from BloombergElon Wants His Money BackDubai Grinds to Standstill as Flooding Hits CityRecord Rainfall in Dubai? Blame Climate Change, Not Cloud SeedingSingapore Loses ‘World’s Best Airport’ Crown to QatarRed Lobster Considers Bankruptcy to Deal With Leases and Labor CostsGains for Treasuries sent the 10-year yield a
Bloomberg•31m ago
Trump Media stock jumps for second day as company goes to battle with short sellers
Trump Media is advising investors on ways to prevent their shares from being loaned for a short-interest position.
Yahoo Finance•12h ago
The Most Active Stock Trader in Congress Is Buying Shares of This Magnificent Stock-Split Stock
Wall Street's most-prominent stock-split stock of 2024 has been purchased on three separate occasions by a lawmaker who completed over 4,200 trades last year.
Motley Fool•20h ago
Billionaire Warren Buffett Recently Cut This Stock From Berkshire Hathaway's Portfolio. It Just Dropped 53% In 1 Day. Here's What Investors Need to Know.
The insurer was accused by a short-seller of "extensive" fraud.
Motley Fool•2d ago
Cathie Wood buys $14 million of Tesla stock
Her flagship Ark Innovation ETF has lost 18% this year.
TheStreet•5h ago
Jamie Dimon Knew Subprime 'Could Go Up In Smoke'; Now He's Worried About An Artificial Economy 'Fueled by Government Deficit Spending'
In the chaos of the 2008 recession, perhaps no bank stood more prepared than Jamie Dimon's J.P Morgan Chase & Co. (NYSE:JPM). In advance of the crisis, Jamie Dimon realized that "underwriting standards were deteriorating across the industry," with late payments on subprime loans rising. In late 2006, the bank led his firm to exit Wall Street's hot subprime business, starting with a frantic call made to J.P. Morgan's vacationing Chief of Securitized Products where he said, "I really want you to w
Benzinga•14h ago
DJT Stock Jumps. The Truth Social Owner Is Showing Stockholders How to Block Short Sellers.
An FAQ on the Truth Social owner’s website gave stockholders multiple ways to avoid their shares being lent to short sellers.
Barrons.com•8h ago
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Pfizer stock remains under pressure despite becoming one of the biggest names of the pandemic. Is PFE stock a sell?
Investor's Business Daily•13h ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

RedHill Biopharma (RDHL) Jumps: Stock Up 8.8% - Tale of the Tape

Recommended Stories

Dow Jones Futures Fall As Israel Strikes Iran; Stock Market About To Break Power Trend

Don't buy the dip in stocks just yet as a wave of selling is about to bring the market to a bottom, according to one of the biggest bulls on Wall Street

Stocks Slump, Havens Surge on Mideast: Markets Wrap

Trump Media stock jumps for second day as company goes to battle with short sellers

The Most Active Stock Trader in Congress Is Buying Shares of This Magnificent Stock-Split Stock

Billionaire Warren Buffett Recently Cut This Stock From Berkshire Hathaway's Portfolio. It Just Dropped 53% In 1 Day. Here's What Investors Need to Know.

Cathie Wood buys $14 million of Tesla stock

Jamie Dimon Knew Subprime 'Could Go Up In Smoke'; Now He's Worried About An Artificial Economy 'Fueled by Government Deficit Spending'

DJT Stock Jumps. The Truth Social Owner Is Showing Stockholders How to Block Short Sellers.

Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?